Online follow-up for patients with papillary thyroid cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of online outpatient follow-up for patients who have undergone surgery for papillary thyroid cancer. It is a randomized, actively controlled, non-inferiority trial set to begin in August 2024 and run until August 2026. Participants must have had thyroid surgery and be able to complete follow-up visits online. The study aims to determine if online follow-up is as effective as traditional in-person visits for monitoring patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria：

* clinical diagnosis of papillary thyroid cancer
* has underwent thyroid surgery (including endoscopic and open thyroid surgery)
* 18 to 90 years of age
* spoke Chinese
* has the ability to use mobile phones and the Internet to complete the visit
* voluntarily participate in clinical trials and sign informed consent.

Exclusion Criteria：

* postoperative hospital stay more than 5 days
* inability to complete an online visit (no access to the device or the Internet
* high risk of postoperative complications (recurrent laryngeal nerve injury, etc.)
* unable to participate due to comorbidities, laboratory test results or physical disability
* pregnancy
* has mental illness or take psychotropic drugs, and were not able to perform the surgery

Where it's running

• West China Hospital
  Chengdu, Sichuan, China Recruiting

Study contacts

• Study coordinator: Jianyong Lei, Md
• Email: leijianyong@scu.edu.cn
• Phone: 86-19983137992

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Radiofrequency ablation for benign or indeterminate thyroid nodules and low‑risk papillary thyroid cancer

  This project sees if radiofrequency ablation shrinks benign or indeterminate thyroid nodules and controls low‑risk papillary thyroid cancer in adults, and how the treatment affects patients' quality of life.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07140757

• Benefits of Carbon Nanoparticles Injection Timing in Thyroid Cancer Treatment

  This study tests whether giving carbon nanoparticles before or during surgery can help people with papillary thyroid cancer have better outcomes and fewer complications.

  Recruiting Phase 3 Second Affiliated Hospital of Xi'an Jiaotong University · Xi'an, Shaanxi · NCT06791005

• Ultrasound-guided thermal ablation for treating papillary thyroid cancer

  This study is testing whether ultrasound-guided thermal ablation can safely and effectively treat small papillary thyroid cancers in patients with less aggressive disease over a follow-up period of at least a year.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT06733740

• Optimizing Levothyroxine Dosage for Patients After Thyroid Surgery

  This study is testing a new tool that helps find the right dose of levothyroxine faster for people who have had their thyroid removed, to see if it improves their health and ability to work compared to regular care.

  Recruiting at 3 sites University Hospital of North Norway · Bergen and 2 other locations · NCT06455371

• Evaluating thermal ablation and surgery for low-risk papillary thyroid cancer

  This study is testing whether a new treatment using heat can be as effective as traditional surgery for people with low-risk thyroid cancer.

  Recruiting Chinese PLA General Hospital · Beijing · NCT06316895

• Comparing biopsy results to surgical samples in thyroid cancer

  This study is testing if the results from small needle biopsies of thyroid cancer match up with those from larger surgical samples to help doctors make better treatment decisions for patients with papillary thyroid cancer.

  Recruiting University of Calgary · Calgary, Alberta · NCT06133374

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.